(1)
Nelaj, E.; Kecaj, I.; Feracaku, J.; Xhixhabesi, K.; Tase, M. Benefits of SGLT2 Inhibitors on Renal and Cardiovascular Protection, in Diabetic Patients. SEEJPH 2024, 200-206.